超越药物治疗:针对心力衰竭特定病理生理机制的治疗方法洞察
心力衰竭是常见且高致残致死性综合征,管理主要基于药物。本文列举针对特定病理生理机制的非药物进展:心脏再同步化与植入式心律转复除颤器治疗电机械不同步与心律失常;压力反射与迷走神经刺激调节神经体液;房间分流预防不良重构;细胞疗法直接靶向心肌以再生心肌细胞。
要点
- 心脏再同步化和植入式心律转复除颤器针对电机械不同步与心律失常。
- 压力反射和迷走神经刺激用于神经体液调节。
- 房间分流预防不良心脏重构,细胞疗法尝试再生心肌细胞。
核心结论
- 心力衰竭管理已有针对特定病理生理机制的非药物进展,包括器械、神经调节、分流和细胞疗法。
研究设计与样本
- 本文为系列论文,列举心力衰竭管理中针对特定病理生理机制的治疗进展示例。
主要发现
- 心脏再同步化和植入式心律转复除颤器治疗电机械不同步和心律失常。
- 压力反射和迷走神经刺激调节神经体液。
- 房间分流预防不良心脏重构。
- 细胞疗法直接靶向心肌以再生新的心肌细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart failure is a common syndrome associated with substantial morbidity and mortality. The management of symptoms and the strategies for improving prognosis have largely been based on pharmacological treatments. The pathophysiology of heart failure is complex because of the multiple causes responsible for this syndrome. This Series paper presents some examples of advances in heart failure management, in which the treatment specifically targets the underlying pathophysiological mechanisms responsible for the symptoms. These treatments include treatment of electromechanical dyssynchrony and dysrhythmia by cardiac resynchronisation and implantable cardioverter-defibrillators; neurohumoral modification by baroreflex and vagal stimulation; prevention of adverse cardiac remodelling by interatrial shunts; and finally targeting the myocardium directly by cell therapy in an attempt to regenerate new myocardial cells.
引用
- Normand C, Kaye DM, Povsic TJ, et al. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. Lancet. 2019. PMID: 30860030. doi:10.1016/S0140-6736(18)32216-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。